Japanese journal of clinical oncology
-
Jpn. J. Clin. Oncol. · Sep 2008
Comparative Study Clinical TrialUndetectable level of prostate specific antigen (PSA) nadir predicts PSA biochemical failure in local prostate cancer with delayed-combined androgen blockade.
To determine optimal predictors with which to select the crucial patients enrolled in delayed-combined androgen blockade (CAB) trials, based on risk factors. ⋯ PSA nadir was the optimal predictive for low stage, non-metastatic population during delayed-CAB.